Intimate partner violence (IPV) persists as a cause of short-term, long-term, and chronic health consequences. The elevated risk of IPV during pregnancy and the postpartum period (P-IPV) is commonly attributed to increased demands for child bearers and intimate partners. P-IPV may impact the health of the child bearer, developing fetus, and post-birth child.
View Article and Find Full Text PDFBackground: Punctal agenesis (PA) is a rare congenital anomaly that can occur in isolation or as part of an underlying syndrome. The benefit of genetic assessment in individuals with PA and clinical features that should prompt molecular workup has not been systematically studied. The aim of this study was to identify ocular and extraocular features associated with PA and determine its association with an underlying syndrome.
View Article and Find Full Text PDFTo date, 770 million people worldwide have contracted COVID-19, with many reporting long-term "brain fog". Concerningly, young adults are both overrepresented in COVID-19 infection rates and may be especially vulnerable to prolonged cognitive impairments following infection. This calls for focused research on this population to better understand the mechanisms underlying cognitive impairment post-COVID-19.
View Article and Find Full Text PDFObjective: In emergency departments (EDs) nationwide, increasing numbers of youths in psychiatric crisis are "boarding," or awaiting psychiatric care in a nonpsychiatric setting. Community stabilization programs may reduce the prevalence of boarding while supporting behavioral health. This study aimed to evaluate ED and inpatient (IP) psychiatric recidivism of youths receiving Crisis and Transition Services (CATS), a community-based program providing in-home behavioral health crisis services.
View Article and Find Full Text PDFOcul Immunol Inflamm
November 2024
Purpose: To evaluate the barriers to adherence with immunomodulatory therapy (IMT) for patients with uveitis across multiple regions of the United States.
Methods: A multi-center survey of adult and pediatric patients with ocular inflammatory diseases undergoing treatment with IMT was conducted between September 2021 and August 2022. Participating sites included Johns Hopkins Wilmer Eye Institute, Wong Eye Institute of the University of Texas at Austin, University of Wisconsin-Madison, University of Minnesota, Veterans Affairs Hospital of Minneapolis, and Washington University of St.